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Purpose: To evaluate the efficacy and safety of laparoscopic renal cryoablation (LRC) 
of small endophytic renal cell carcinoma, for which surgical treatment is technically 
difficult.
Materials and Methods: We enrolled patients with endophytic tumors from a pro-
spectively collected database of 45 renal tumors in 39 patients who had undergone LRC 
from June 2005 to May 2009. An endophytic tumor was defined as less than 40% of the 
lesion extending off the surface of the kidney. We evaluated surgical and oncological 
outcomes. 
Results: Among the treated tumors, 17 tumors (37.8%) were defined as endophytic tu-
mors and 15 tumors from 14 patients were confirmed as renal cell carcinoma (RCC) 
in the pathologic examination of the tissue biopsy that was conducted at the time of 
LRC. The mean American Society of Anesthesiologists (ASA) score of the whole patient 
group was 2.9 (range, 1-4), and 85.7% (12/14) of the patients had an ASA physical status 
score over 3. The mean tumor size was 2.8 cm (range, 1.7-3.7 cm). The layout of the cryop-
robe was carefully planned preoperatively on the basis of radiologic evaluation in all 
tumors. Multiple cryoprobes (mean, 3.2; range, 2-5) were used. No major complications, 
including open surgical conversion and nephrectomy due to bleeding, occurred. No pa-
tient experienced clinical symptoms of collecting system injuries. During the mean fol-
low-up of 32.6 months (range, 12-51 months), radiologic evidence of tumor recurrence 
was found in one patient (6.7% for RCC). With the exception of this patient, all other 
patients have remained free of recurrence or metastasis, as determined by periodic ra-
diologic workups.
Conclusions: In this series of patients with intermediate-term follow-up, LRC for endo-
phytic renal cell carcinoma showed acceptable oncological and surgical outcomes with-
out sequelae in the collecting system. 
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INTRODUCTION 
Whereas the management of localized renal cell carcinoma 
(RCC) has evolved toward minimally invasive and neph-
ron-sparing surgery, the treatment of endophytic renal tu-
mors has remained problematic. These tumors typically re-
quire precise intracorporeal suturing and complex re-
construction, with the added time constraints imposed by 
renal ischemia. Even open partial nephrectomy is ac-
knowledged to be technically demanding in this situation, 
with increased complication rates compared with proce-
dures for tumors in peripheral locations [1]. In addition, se-
rial studies of laparoscopic partial nephrectomy (LPN) re-
port higher postoperative complication rates, which result Korean J Urol 2010;51:518-524
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FIG. 1. An example of an endophytic 
tumor. (A) The preoperative CT image
showed a 2.8 cm well-enhanced mass 
in the right kidney at a distance of 2.6 
mm (white arrow) from the collecting 
system. (B) At 18 months after 
surgery, the ablated region had dimi-
nished in size, and no region with 
enhancement was observed.
in more ischemic time and longer hospital stays for endo-
phytic tumors [2-4].
　With the increasing application of minimally invasive 
surgery, several energy-based tissue ablation technologies 
including cryoablation and radiofrequency ablation are be-
ing investigated. In these procedures, tissue is destroyed 
in situ, thereby avoiding the complications induced by re-
nal ischemia and surgical excision. Although energy-based 
ablation may injure the collecting system, clinical and pre-
clinical studies on cryoablation have demonstrated the 
ability of this technique to manage tumors located almost 
within the collecting system without compromising the in-
tegrity of the underlying structure [5-7]. In addition, the 
laparoscopic approach allows the surgeon to position the 
cryoprobe by using intraoperative ultrasonography more 
precisely and to move adjacent organs away from the abla-
tion site. If the surgical and oncological outcomes support 
the feasibility and efficacy of laparoscopic cryoablation 
(LRC) for endophytic renal tumors, and safety can be main-
tained during the surgical procedure, this method may pro-
vide an alternative nephron-sparing surgery for selected 
patients. To determine this, we evaluated the inter-
mediate-term outcome of LRC in patients with endophytic 
RCC. 
MATERIALS AND METHODS
1. Patients and data collection
From June 2005 to May 2009, LRC was performed on 45 
renal tumors in 39 patients at our institution. Indications 
for LRC included the presence of a localized, solid enhanc-
ing renal mass smaller than 4 cm in a patient at high risk 
for partial nephrectomy or older than 70 years of age [8]. 
High operative risk in our institution was defined as an 
American Society of Anesthesiology (ASA) physical status 
score of over 3 [9]. Among these inclusion criteria for LRC, 
absolute indications included bilateral tumors and a pa-
tient with a solitary kidney or renal insufficiency. A patient 
with normal contralateral renal function but poor oper-
ability was defined as an elective indication. All patients 
underwent a preoperative radiologic evaluation with con-
trast-enhanced computed tomography (CT) or magnetic 
resonance imaging (MRI) in the case of renal insufficiency 
to delineate the parameters of the renal lesion, including 
location, size, depth, and position relative to hilar vessels 
and the collecting system. 
　All patients who underwent LRC in our institution were 
registered prospectively in a specific database that in-
cluded all important information about tumor and patient 
characteristics including operative time, blood loss, hospi-
tal stay, pathology findings, and occurrence of compli-
cations. This allowed us to collect and analyze the data of 
the patients retrospectively, depending on the location of 
the tumor and pathologic findings. Three attending urolo-
gists reviewed the preoperative imaging studies for each 
patient to categorize the renal mass depending on tumor 
position. An endophytic location of a tumor in this study 
was defined as less than 40% of the lesion extending off the 
surface of the kidney (Fig. 1), as originally described by 
Finley et al [10]. Among all patients who underwent LRC, 
15 tumors from 14 patients who were confirmed as having 
RCC by intraoperative needle biopsy and were followed up 
minimally for 12 months were exclusively enrolled in this 
series. 
　Patients were initially evaluated at 1 month and 3 
months, then every 3 months during the first year. They 
were evaluated every 6 months during the second year and 
then annually. Follow-up evaluations involved a medical 
history update, physical examination, blood pressure 
measurement, contrast-enhanced CT or MRI, chest ra-
diography, measurement of serum electrolytes, liver func-
tion tests, and renal function tests. A lack of enhancement 
on CT or MRI along with stable or decreased tumor size 
were considered signs of successful treatment. Recurrence Korean J Urol 2010;51:518-524
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TABLE 1. The perioperative characteristics of the patients
No. of patients with endophytic    14 
 renal cell carcinoma
No. of endophytic renal cell    15 
 carcinoma treated 
Mean age (years)    61.4 (43-75) 
Male     11 
Female      3
Mean size of renal mass (cm)      2.8 (1.7-3.7) 
ASA physical status score      2.9 
Indication 
Bilateral      2 
Solitary     3
Chromic renal failure      1 
Elective      8 
Approach method
Transperitoneal     9
Retroperitoneal      6 
Tumor side
Right side    10
Left side      5 
Operation time (min)  169.7 (110-220) 
No. of needle      3.2 (2-5) 
Blood loss (ml)    99.5 (40-150) 
Transfusion (% of rate)         1 (7.1) 
Mean hospital stay (day)      4.1 (3-8) 
Mean creatinine (mg/dl) 
Pre-operation    1.31 (0.9-2.1)
 p=0.13
Post-operation (POD 7)    1.43 (0.9-2.3) 
Mean hemoglobin (g/dl) 
Pre-operation 13.94  (8.4-15.7) 
p=0.57
Post-operation (POD 7) 13.21  (9.1-14.2) 
Complication 
Open surgical conversion      0 
Nephrectomy for bleeding      0 
Adjacent organ injury      0 
Perirenal hematoma      0 
Urine leakage      0 
Mean follow up (months)    32.6 (12-51) 
Recurrence (% of rate)        1 (6.7) 
Metastasis      0 
ASA: American Society of Anesthesiology, POD: postoperative 
day
was defined as increasing tumor size or lack of tumor 
shrinkage, with image enhancement [11]. 
2. Operative techniques
All LRC procedures were conducted by a single surgeon 
with use of nearly identical technique. For the laparoscopic 
procedure, a standard technique using three ports was 
performed. In general, tumors anterior to a horizontal line 
within the coronal plane through the renal hilum were ap-
proached transperitoneally, and tumors posterior to this 
line were approached retroperitoneally. Real-time intra-
operative ultrasonography (IOUS: Aloka Dynaview II, 
Americanlab, Miami, FL, USA) was used in all cases to 
identify the lesion and to determine the degree of the ice 
ball extension. The kidney was mobilized and the Gerota’s 
fascia was opened to facilitate identification of the tumor. 
The fat overlying the tumor was placed aside and later re-
trieved for pathology examination. Up to two needle biop-
sies were taken from the tumor before the insertion of a 
cryoprobe. Then 1.47 mm cryoprobes (IceRod, Oncura, 
Plymouth Meeting, PA, USA) were inserted, each of which 
induced a −40
oC isothermal lesion 14.5x34 mm in diame-
ter and radiating from the ablation probe. Before insertion 
into the kidney, the proper number and positions of the cry-
oprobes were carefully calculated on the basis of the pre-
operative imaging study and IOUS. Temperature probes 
were then inserted into the deep margins of the tumor. In 
all cases, a double-freeze cycle was applied, with an inter-
vening thawing process. At the base of a lesion in proximity 
to the collecting system, the extent of the ice ball was identi-
fied by IOUS as a complete loss of echogenic lesion in the 
circumferential area of the base. Hemostasis was achieved 
by filling the probe tract with fibrin glue (Baxter, Deerfield, 
Il) and Surgicel (Johnson & Johnson, Irvine, CA, USA) af-
ter the second thaw allowed the safe removal of the 
cryoprobe. 
3. Statistical analysis
All data were analyzed with the Statistical Package for the 
Social Sciences, version 13 (SPSS Inc, USA). Statistical 
comparison of pre- and postoperative values was per-
formed with paired t-tests, with differences considered 
statistically significant if p＜0.05.
RESULTS
Among 45 renal tumors treated with LRC in our in-
stitution, 17 (37.8%) were defined as endophytic tumors. 
Among them, 15 tumors from 14 patients were confirmed 
as RCCs and were exclusively enrolled in this series. Five 
tumors were centrally located, which was defined as being 
completely surrounded by normal parenchyma [12], with 
no visual clue regarding the location of the tumor on 
laparoscopy. One patient had a hilar tumor, which was de-
fined as a tumor positioned medially within 5 mm of the re-
nal artery or vein [13]. 
　The patient demographics, perioperative character-
istics, and outcomes are summarized in Table 1. The mean 
(range) age of the 14 enrolled patients was 61.4 years 
(range, 43-75 years) old. Four patients (28.6%) were over 
70 years old, and their mean age was 72.8 years (range, 
70-75 years) old with a mean ASA physical status score of 
2.3 (range, 1-3). The other 10 patients had ASA physical 
status scores over 3. The mean ASA physical status score 
of the whole patient group was 2.9 (range, 1-4), and 85.7% 
(12/14) of patients had an ASA physical status score over 
3. The indications for nephron-sparing surgery included a 
bilateral tumor in 2 patients, solitary kidney tumors in 3 
patients, and chronic renal failure in 1 patient. The peri-
operative outcome of each patient is shown in Table 2.
　The mean tumor size was 2.8 cm (range, 1.7-3.7 cm) and Korean J Urol 2010;51:518-524
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FIG. 2.  Serial changes in a right endophytic tumor before and after cryoablation. (A) The preoperative CT image showed a 2.0 cm 
tumor mass encompassed by renal parenchyma in the lower pole of the right kidney. (B) Postoperative image at 3 months. (C) 
Postoperative image at 12 months. (D) In this image 24 months after surgery, the ablated lesion had nearly vanished.
the mean operating time was 169.7 minutes (range, 
110-220 minutes). The mean time of the first freeze cycle 
was 7.9 minutes, and the mean of the second freeze cycle 
was 7.4 minutes. In the case of five central tumors, more 
fat tissue overlying the kidney was removed to achieve an 
adequate image for monitoring the position of the cryop-
robe tip. In the case of a hilar tumor, the major renal vessels, 
ureter, and renal pelvis were displaced from the ice ball 
with vascular loops, and rolled gauze was placed into the 
renal hilum. In all patients, multiple cryoprobes were used, 
and the mean number of cryoprobes needed was 3.2 (range, 
2-5). The mean blood loss, measured as the amount in the 
suction device, was 99.5 ml (range, 40-150 ml). 
　No major complications, including open surgical con-
version and nephrectomy due to bleeding, occurred in any 
patient. The serum creatinine and hemoglobin levels 
checked 7 days after surgery showed no significant differ-
ences compared with preoperative levels. The average pre-
operative and postoperative creatinine levels were 1.31 
mg/dl and 1.43 mg/dl, respectively (p=0.13). The average 
preoperative and postoperative hemoglobin levels were 
13.94 g/dl and 13.21 g/dl, respectively (p=0.57). One patient 
who had a previous subtotal gastrectomy for early gastric 
adenocarcinoma needed a postoperative transfusion due to 
a low preoperative baseline hemoglobin level (8.4 g/dl). The 
mean hospital stay was 4.1 days (range, 3-8 days), and dur-
ing this stay, no one experienced clinical signs or symptoms 
of collecting system injuries, including flank pain, fever, 
and leukocytosis. In the pathologic examination, all of the 
patients showed common clear cell carcinoma, RCC, except 
for two patients with papillary type 1. Eight tumors were 
Fuhrman grade 2, and the others were grade 3. 
　The mean follow-up was 32.6 months (range, 12-51 
months). Follow-up imaging studies revealed no evidence 
of hydronephrosis, and all patients remained asympto-
matic. Radiologic evidence of improper ablation was found 
in one patient (6.7%). A 2.2 cm sized central tumor was in 
direct contact with the collecting system, as shown by the 
enhancing portion in the deep peripheral area of the cry-
oablated site in an initial follow-up CT taken 1 month after 
LRC. Due to his high anesthesiologic risk from myocardial 
infarction, which required vascular stenting 3 times, and 
the anterior location of the tumor, which disturbs deploy-
ment of the probes for other minimally invasive ablative 
techniques including radiofrequency ablation, this patient 
is currently under active surveillance. Follow-up images Korean J Urol 2010;51:518-524
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FIG. 3. Changes in the mean tumor size after renal cryoablation.
showed no increase in the enhancing lesion or distant meta-
stasis for 24 months after the initial LRC. Except for this 
patient, all other patients have remained free of recurrence 
or metastasis as shown by the periodic radiologic workups. 
The mean size of these properly treated lesions was 2.75± 
0.72 cm, 2.96±0.42 cm, 2.71±0.26 cm, 2.43±0.19 cm, 2.24 
±0.21 cm, 1.26±0.31 cm, and 1.08±0.34 cm before surgery, 
and at 1 month, 3 months, 6 months, 9 months, 12 months, 
and 24 months, respectively (Fig. 2, 3).
DISCUSSION 
Because small renal tumors emerge incidentally during 
imaging for various indications, questions persist about 
the best way to treat endophytic tumors with a minimally 
invasive technique. Although 3-, 5-, and 10-year-old data 
encourage the use of renal cryoablation, especially for tu-
mors in peripheral locations [14-16], extending these find-
ings to endophytic tumors is still under debate. Because of 
the proximity to the renal vasculature and the collecting 
system, the cryoablation of an intraparenchymal endo-
phytic tumor can potentially be disturbed by natural heat 
sinks, including the blood and urine. Actually, Wright et 
al reported two cases of treatment failure, both in endo-
phytic tumors (i.e., completely intrarenal lesions), among 
35 LRC lesions during an 18-month follow-up [17]. In the 
multivariate analysis in their study, only the endophytic 
status of a lesion predicted treatment failure. In contrast 
to this, Hurby et al reported the successful treatment by 
LRC in all 11 patients with tumors located within 5 mm of 
the renal vasculature during 11.3 months of follow-up [13]. 
Considering the technical difficulty of LPN in endophytic 
and hilar lesions, Nisbet et al formulated an algorithm on 
the basis of published series outcomes that recommended 
LRC for endophytic and LPN for exophytic and mesophytic 
lesions [18]. 
　Our results provide additional evidence for the efficacy 
of LRC for the treatment of endophytic tumors. With inter-
mediate-term follow-up, whereas 1 among 15 RCC lesions 
was managed improperly with LRC, the other lesions have 
remained free of recurrence or metastasis. Although we 
studied a small number of patients, the treatment failure 
rate of 6.7% in our series agrees with the positive margin 
rate of 1-7.4% in partial nephrectomy [19]. This result pro-
vides us with technical clues for successful ablation in cases 
of endophytic lesions. The first is the careful preoperative 
design of the layout of the cryoprobes. We usually planned 
the position of the cryoprobe tip on the basis of the pre-
operative imaging, including CT or MRI. In our series, the 
skin insertion site of each probe, the depth of insertion of 
the cryoprobe into the tumor in the operative filed, and the 
number of cryoprobes were decided on preoperatively on 
the basis of the shape, location, and diameter of the tumor. 
The sagittal and/or coronary sections of these images pres-
ent additional information for this purpose. The IOUS im-
age is also valuable, especially in guiding the location of the 
cryoprobe for endophytic tumors, because laparoscopic vis-
ual cues alone do not permit precise localization of cryop-
robe tips, leaving IOUS as the only mode of real-time 
imaging. However, the image during freezing is distorted 
by several factors, including artifacts at the leading edge 
of the ice ball and inability to monitor the periphery of the 
mass, as noted by Badger et al [20]. In our LRC experience 
with endophytic tumors, the capacity of IOUS to monitor 
ice ball expansion is limited, especially for endophytic in-
traparenchymal tumors, because the collecting system it-
self behaves as an anechoic lesion. 
　To inflict lethal freezing injury throughout the tumor 
volume while sparing normal healthy tissues, the targeted 
lesion should be located within the lethal area of cryoa-
blation, and a temperature below −40
oC is usually re-
quired to effectively destroy malignant renal tissue [21]. 
Unfortunately, no tool currently available can precisely de-
fine the three-dimensional configuration of this critical iso-
thermal surface during cryoablation. Thus, we surmise 
that the use of multiple cryoprobes is more practical than 
focusing on the accuracy of the cryoprobe itself for conduct-
ing LRC for an endophytic lesion. Hypothetically, this ap-
proach might increase freezing efficiency by extending the 
coldest isothermal line, as compared with a single probe, 
and the distribution of the probes across the tumor might 
also compensate for an asymmetric tumor shape. Particu-
larly for an intraparenchymal tumor, the use of multiple 
cryoprobes may have the additional advantage of evading 
the natural heat sink effect, a barrier intrinsic in low-tem-
perature-based ablation. 
　One challenge a surgeon faces in a partial nephrectomy, 
whether open or laparoscopic, on a patient with an endo-
phytic renal tumor is reconstruction of the collecting 
system. Cryoablation averts this challenge, but not the risk 
of injury to the collecting system, with resultant urine leak-
age, particularly for endophytic and deep lesions. However, 
recent reports on renal cryoablation support the tolerance 
of the collecting system to the radiographic ice ball formed 
in the procedure. Targeted renal pelvic cryoablation re-
sulted in no urinary extravasations from a total of 15 le-
sions in a swine model [5]. In a clinical setting, six patients Korean J Urol 2010;51:518-524
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with intraparenchymal tumors who were treated by percu-
taneous cryoablation revealed no clinical evidence of ure-
teral sequelae [6]. In a comparison of 11 LRC and 12 LPN 
procedures for hilar tumors that were defined as located 
within 5 mm of the renal vasculature, the LRC group expe-
rienced no complications, whereas the complication rate of 
the LPN group was 50%, with urine leakage being the most 
significant complication [13]. Similarly, in our series of 14 
patients with endophytic tumors, none showed clinical or 
radiological evidence of collecting system injury during the 
minimum follow-up of 28 months. These studies together 
support the safety of the cryoablative ice ball for the under-
lying structure of the kidney.
　We still recognize several limitation of this series, includ-
ing this being the experience of a single institution for a rel-
atively small number of cases. The noncomparative, retro-
spective study design may also limit the application of our 
findings. Obviously, to establish the effectiveness of a new 
technique, prospective studies must be conducted to com-
pare the new technique with conventional methods. 
However, it deserves notice that our patient criteria for 
LRC included high risk for anesthesia with severe co-mor-
bidity or relatively old age, leaving LRC as the last surgical 
treatment option. Still, the application of cryoablation to 
renal tumors is currently in the investigational stage, de-
spite the promising reported clinical outcomes. Therefore, 
although our data showed the intermediate-term oncologic 
efficacy of LRC, longer follow-up with larger scale series is 
still needed before ablative technologies can be established 
as a valid alternative option for the treatment of renal tu-
mors and before their indication can be expanded to endo-
phytic renal tumors. 
CONCLUSIONS
In this series with an intermediate-term follow-up, LRC for 
small endophytic tumors showed acceptable oncological 
and surgical outcomes without adverse effects in the col-
lecting system. These results also emphasize that careful 
preoperative design of the layout of the cryoprobes and the 
use of multiple cryoprobes should be given special consid-
eration, especially in endophytic cases. However, further 
studies with longer term follow-up and larger patient 
groups are needed to establish the position of ablative tech-
nologies in the treatment of renal tumors and to extend 
their application to renal tumors in endophytic locations. 
Conflicts of Interest
The authors have nothing to disclose.
REFERENCES
1. Hafez KS, Novick AC, Butler BP. Management of small solitary 
unilateral renal cell carcinomas: impact of central versus periph-
eral tumor location. J Urol 1998;159:1156-60.
2. Frank I, Colombo JR Jr, Rubinstein M, Desai M, Kaouk J, Gill 
IS. Laparoscopic partial nephrectomy for centrally located renal 
tumors. J Urol 2006;175:849-52.
3. Venkatesh R, Weld K, Ames CD, Figenshau SR, Sundaram CP, 
Andriole GL, et al. Laparoscopic partial nephrectomy for renal 
masses: effect of tumor location. Urology 2006;67:1169-74.
4. Reisiger K, Venkatesh R, Figenshau RS, Bae KT, Landman J. 
Complex laparoscopic partial nephrectomy for renal hilar 
tumors. Urology 2005;65:888-91.
5. Brashears JH 3rd, Raj GV, Crisci A, Young MD, Dylewski D, 
Nelson R, et al. Renal cryoablation and radio frequency ablation: 
an evaluation of worst case scenarios in a porcine model. J Urol 
2005;173:2160-5.
6. Warlick CA, Lima GC, Allaf ME, Varkarakis I, Permpongkosol 
S, Schaeffer EM, et al. Clinical sequelae of radiographic iceball 
involvement of collecting system during computed tomography- 
guided percutaneous renal tumor cryoablation. Urology 2006;67: 
918-22.
7. Cestari A, Guazzoni G, dell'Acqua V, Nava L, Cardone G, Balconi 
G, et al. Laparoscopic cryoablation of solid renal masses: inter-
mediate term followup. J Urol 2004;172:1267-70.
8. Stein RJ, Kaouk JH. Renal cryotherapy: a detailed review includ-
ing a 5-year follow-up. BJU Int 2007;99:1265-70. 
9. Forrest JB, Rehder K, Cahalan MK, Goldsmith CH. Multicenter 
study of general anesthesia. III. Predictors of severe perioper-
ative adverse outcomes. Anesthesiology 1992;76:3-15.
10. Finley DS, Lee DI, Eichel L, Uribe CA, McDougall EM, Clayman 
RV. Fibrin glue-oxidized cellulose sandwich for laparoscopic 
wedge resection of small renal lesions. J Urol 2005;173:1477-81.
11. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 
3rd, Dupuy DE, et al. Image-guided tumor ablation: stand-
ardization of terminology and reporting criteria. J Vasc Interv 
Radiol 2005;16:765-78.
12. Black P, Filipas D, Fichtner J, Hohenfellner R, Thüroff JW. 
Nephron sparing surgery for central renal tumors: experience 
with 33 cases. J Urol 2000;163:737-43.
13. Hruby G, Reisiger K, Venkatesh R, Yan Y, Landman J. 
Comparison of laparoscopic partial nephrectomy and laparo-
scopic cryoablation for renal hilar tumors. Urology 2006;67:50-4. 
14. Weld KJ, Figenshau RS, Venkatesh R, Bhayani SB, Ames CD, 
Clayman RV, et al. Laparoscopic cryoablation for small renal 
masses: three-year follow-up. Urology 2007;69:448-51.
15. Berger A, Kamoi K, Gill IS, Aron M. Cryoablation for renal tu-
mors: current status. Curr Opin Urol 2009; 19:138-42.
16. Aron M, Kamoi K, Haber GP, Desai MM, Canes D, Kaouk JH, et 
al. Laparoscopic renal cryoablation: long term oncologic outcomes 
with minimum 5- year follow-up. J Urol 2008;179(Suppl 1): 
209-10, abstract 596
17. Wright AD, Turk TM, Nagar MS, Phelan MW, Perry KT. 
Endophytic lesions: a predictor of failure in laparoscopic renal 
cryoablation. J Endourol 2007;21:1493-6. 
18. Nisbet AA, Rieder JM, Tran VQ, Williams SG, Chien GW. 
Decision tree for laparoscopic partial nephrectomy versus laparo-
scopic renal cryoablation for small renal masses. J Endourol 
2009;23:431-7.
19. Lam JS, Bergman J, Breda A, Schulam PG. Importance of surgical 
margins in the management of renal cell carcinoma. Nat Clin 
Pract Urol 2008;5:308-17. 
20. Badger WJ, de Araujo HA, Kuehn DM, Angresen KJ, Winfield 
HN. Laparoscopic renal tumor cryoablation: appropriate applica-
tion of real-time ultrasonographic monitoring. J Endourol 
2009;23:427-30.
21. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 
2005;95:1187-91.